Accelerate Diagnostics Inc. (NASDAQ: AXDX)
$1.6650
-0.1250 ( -6.98% ) 25.6K
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
Market Data
Open
$1.6650
Previous close
$1.7900
Volume
25.6K
Market cap
$39.31M
Day range
$1.6550 - $1.7900
52 week range
$0.7300 - $7.4350
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 15, 2023 |
10-q | Quarterly Reports | 98 | Aug 14, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |